Quantitative MR in the diagnosis of multiple sclerosis
- 1 July 1992
- journal article
- research article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 26 (1) , 71-78
- https://doi.org/10.1002/mrm.1910260108
Abstract
In patients with multiple sclerosis (MS), the apparently uninvolved cerebral white matter between demyelinated plaques may have biochemical abnormalities. To what degree the changes in the white matter contribute to symptomatology in MS is unknown. In 39 patients with multiple sclerosis, and in 39 age-matched nondiseased volunteers, T1 and T2 were calculated from spin-echo images in four regions of apparently uninvolved white matter. In three of four white matter areas, the average T1 and T2 were significantly longer in the patients than in the controls. The T1 correlated with the disability, measured by the Kurtzke Extended Disability Status Scale, although the correlation was marginally significant. The results suggest that in patients with MS, white matter disease that is not visualized in MR as distinct foci of abnormal signal intensity may contribute to disease burden and disability.Keywords
This publication has 20 references indexed in Scilit:
- T1 and T2 measurements on a 1.5-T commercial MR imager.Radiology, 1989
- Reproducibility of relaxation and spin-density parameters in phantoms and the human brain measured by MR imaging at 1.5TMagnetic Resonance in Medicine, 1986
- Brain tumors: detection and typing by use of CPMG sequences and in vivo T2 measurements.Radiology, 1985
- Magnetic resonance of the chest: initial experience with imaging and in vivo T1 and T2 calculations.Radiology, 1984
- Chronic liver disease: evaluation by magnetic resonance.Radiology, 1984
- A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosisJournal of the Neurological Sciences, 1979
- Myelin in Multiple SclerosisArchives of Neurology, 1973
- PROTEOLYTIC ACTIVITY AND BASIC PROTEIN LOSS IN AND AROUND MULTIPLE SCLEROSIS PLAQUES: COMBINED BIOCHEMICAL AND EIISTOCHEMICAL OBSERVATIONSJournal of Neurochemistry, 1972
- NEUROLOGIC IMPAIRMENT IN MULTIPLE SCLEROSIS AND THE DISABILITY STATUS SCALEActa Neurologica Scandinavica, 1970
- PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSISAnnals of the New York Academy of Sciences, 1965